Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management-Reference-Cited by-同舟云学术

Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management

Published:2021-08 Issue: Volume:Volume 14 Page:1069-1080
ISSN:1178-7066
Container-title:Pharmacogenomics and Personalized Medicine
language:en
Short-container-title:PGPM

Author:

Eljilany Islam^ORCID,Elarref Mohamed,Shallik Nabil^ORCID,Elzouki Abdel-Naser^ORCID,Bader Loulia,El-Bardissy Ahmed,Abdelsamad Osama,Al-Badriyeh Daoud,Cavallari Larisa H,Elewa Hazem^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology,Molecular Medicine

Reference53 articles.

1. Pharmacology and Management of the Vitamin K Antagonists

2. Trends in oral anticoagulant use in Qatar: a 5-year experience

3. Direct Oral Anticoagulant Use in Atypical Thrombosis-Related Conditions

4. Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population

5. How Well Does the Target INR Level Maintain in Warfarin-Treated Patients with Non-ValvularAtrial Fibrillation?

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. QPGx‐CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies;Clinical and Translational Science;2024-05-31

2. Genetic Factors Associated with Morphine Consumption in Women Undergoing Laparoscopic Cholecystectomy: A Prospective Cohort Study;Journal of Pain Research;2023-07

3. Warfarin pharmacogenetics in a black Zimbabwean cohort: an observational prospective study;Pharmacogenomics;2023-07

4. Cost-Benefit Analysis of Genotype-Guided Interruption Days in Warfarin Pre-Procedural Management;Current Problems in Cardiology;2023-06